Nagy Habib

Nagy Habib

Company: MiNa Therapeutics

Job title: Founder & Head of R&D

Seminars:

Sharing Clinical Findings from Modulating Myeloid Cells at Their Inception with Small Activating RNA Therapies to Enhance Anti-Tumor Activity 11:30 am

• Describing the mode of action of saRNA therapies targeting naïve myeloid cells • Developing a preclinical package for next-generation myeloid-targeted therapies and translating them into the clinic • Outlining how indications and patient populations were chosen, and how to best utilize tumor biomarkers as an indicator mechanism • Sharing patient outcomes, toxicology studies, and…Read more

day: Day Two

Panel Discussion: Discussing Future Directions in Myeloid-Directed Therapy Development 10:30 am

• Acknowledging the limitations of current therapies and the role of the myeloid compartment • Examining roadblocks to development of myeloid-directed therapy to-date • Charting future developments in myeloid therapies and discussing the emerging treatment landscape for myeloid therapies • Considering where will the greatest therapeutic benefit of myeloid-directed therapy be realizedRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.